dMed is a biopharmaceutical company that facilitates the globalization of innovative drugs, accelerates the development of medicines and improves clinical development capabilities. Its research organization provides advisory services on the basis of a clinical development plan, regulatory strategy, approval processes, and clinical trial support. This enables biopharmaceutical and medical companies to improve clinical trial efficiency and thereby increase the probability of their products' success.